已收盘 01-11 16:00:00 美东时间
0.000
0.00%
根据中国药物临床试验登记与信息公示平台最新公示,默沙东(MRK.US)用于治疗原发性血小板增多症的1类口服新药MK-3543(bomedemstat)启动3期临床研究。
2024-07-24 16:58
默沙东完成了以13.5亿美元现金收购临床阶段生物制药公司Imago BioSciences的收购要约。
2023-01-11 21:13
Shares of Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) saw an uptick in t...
2023-01-10 01:12
Emerald Advisers LLC grew its position in shares of Imago BioSciences, Inc. (NA...
2023-01-03 22:41
Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) CFO Laura G. Eichorn sold 3,...
2022-12-31 18:01
Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) was the recipient of a large...
2022-12-31 14:02
Shares of Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) have earned a cons...
2022-12-30 16:52
Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) insider Michael Arenberg sol...
2022-12-30 07:32
Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) insider Michael Arenberg sol...
2022-12-30 07:22
Imago BioSciences, Inc. (NASDAQ:IMGO – Get Rating) has been assigned an average...
2022-12-23 16:22